Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic drugs in asthma.

G Anderson

    Postgraduate Medical Journal
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Ketotifen, a potential successor to disodium cromoglycate, shows doubtful benefit for asthma treatment. While it may offer a weak prophylactic effect, its overall efficacy remains uncertain.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hurricane power outage burden lands unequally: satellite evidence across 30 Atlantic storms.

    Research square·2026
    Same author

    Mental health disorder symptom changes among public safety personnel after emotional resilience skills training.

    Comprehensive psychiatry·2025
    Same author

    The association between patient activation and healthcare resources utilization: a systematic review and meta-analysis.

    Public health·2022
    Same author

    Mitochondria and immunity in chronic fatigue syndrome.

    Progress in neuro-psychopharmacology & biological psychiatry·2020
    Same author

    Mutations in LAMB2 Are Associated With Albuminuria and Optic Nerve Hypoplasia With Hypopituitarism.

    The Journal of clinical endocrinology and metabolism·2019
    Same author

    Pythium, Phytophthora, and Phytopythium spp. Associated with Soybean in Minnesota, Their Relative Aggressiveness on Soybean and Corn, and Their Sensitivity to Seed Treatment Fungicides.

    Plant disease·2019
    Same journal

    Dapagliflozin-induced anaphylactic shock.

    Postgraduate medical journal·2026
    Same journal

    Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

    Postgraduate medical journal·2026
    Same journal

    Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

    Postgraduate medical journal·2026
    Same journal

    Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

    Postgraduate medical journal·2026
    Same journal

    Care, cash, and proof: forensic accountability for war-related starvation.

    Postgraduate medical journal·2026
    Same journal

    Response to traumatic injuries in polo players in England.

    Postgraduate medical journal·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Respiratory Medicine
    • Allergy and Immunology

    Background:

    • Disodium cromoglycate was a key medication for asthma management.
    • The development of effective successors to disodium cromoglycate has been challenging.
    • Asthma treatment requires ongoing research into novel therapeutic agents.

    Purpose of the Study:

    • To review published studies on the efficacy of ketotifen in asthma.
    • To evaluate ketotifen as a potential successor to disodium cromoglycate.
    • To determine the clinical benefit of ketotifen for asthma patients.

    Main Methods:

    • Systematic review of existing clinical trials and research papers.
    • Analysis of data regarding ketotifen's effectiveness in asthma management.

    Related Experiment Videos

  • Comparison of ketotifen's prophylactic and therapeutic effects.

    • Main Results:

    • Published studies indicate that ketotifen's benefit in asthma is questionable.
    • Ketotifen may possess a mild prophylactic effect in some asthma cases.
    • Evidence for significant therapeutic benefit of ketotifen in asthma is limited.

    Conclusions:

    • Ketotifen is unlikely to be a successful successor to disodium cromoglycate.
    • The prophylactic role of ketotifen in asthma warrants further investigation.
    • Current evidence suggests limited clinical utility for ketotifen in asthma treatment.